Health Condition 1: H350- Background retinopathy and retinalvascular changes
Conditions
Interventions
Intervention1: Anti vascular endothelial growth factor: Anti vascular endothelial growth factor shall be injected intravitrealy in patients with diabetic retinopathy and optical coherence tomography a
Sponsors
Maulana Azad Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Patients in the age group of 18-50 years with type 1 or 2 diabetes mellitus due to center involving diabetic macular edema (CFT of more than or equal to 300 micrometers) who are naive to treatment with anti VEGF Subjects having best corrected visual acuity of atleast 6/60
Exclusion criteria
Exclusion criteria: Subjects having other significant ocular or systemic diseases like glaucoma, media opacity, optic atrophy other retinal diseases especially those which affect macular perfusion Risk of thromboembolic events and/or occurence of these within past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Optical coherence tomography angiography parameters following anti VEGF Foveal Avascular Zone Vessel density (Superficial capillary plexus , Deep capillary plexus, VD full)Timepoint: 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in best corrected visual acuity following anti VEGF changes in Posterior segment Optical Coherence Tomography parameters(Central foveal thickness and sub foveal choroidal thickness) following anti VEGFTimepoint: 1 month | — |
Countries
India
Contacts
Public ContactDr Aman Singh Rana
Maulana Azad Medical College
Outcome results
None listed